Hongjian Yang

435 total citations
20 papers, 313 citations indexed

About

Hongjian Yang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hongjian Yang has authored 20 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Hongjian Yang's work include Cancer-related molecular mechanisms research (6 papers), RNA Research and Splicing (6 papers) and RNA modifications and cancer (4 papers). Hongjian Yang is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), RNA Research and Splicing (6 papers) and RNA modifications and cancer (4 papers). Hongjian Yang collaborates with scholars based in China, South Korea and United States. Hongjian Yang's co-authors include Xingfei Yu, Xiangming He, Xiping Zhang, Yabing Zheng, Xianghou Xia, Xianfeng Ding, Zhiqiang Lin, Fengmei Wang, Shaoju Gan and Ting Ji and has published in prestigious journals such as PLoS ONE, Amino Acids and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Hongjian Yang

19 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongjian Yang China 10 234 160 62 34 25 20 313
Huangzhen Wang China 8 225 1.0× 135 0.8× 60 1.0× 26 0.8× 16 0.6× 8 268
Binbin Cui China 12 197 0.8× 123 0.8× 87 1.4× 56 1.6× 28 1.1× 20 340
Jing Cui China 13 213 0.9× 152 0.9× 88 1.4× 35 1.0× 23 0.9× 19 328
Qianfeng Shi China 6 253 1.1× 158 1.0× 114 1.8× 71 2.1× 19 0.8× 10 360
Maria Sandbothe Germany 7 295 1.3× 210 1.3× 49 0.8× 20 0.6× 36 1.4× 8 370
Faying Xu China 4 289 1.2× 115 0.7× 105 1.7× 41 1.2× 27 1.1× 6 391
Rosario Machado-Pinilla Spain 11 391 1.7× 91 0.6× 73 1.2× 36 1.1× 23 0.9× 11 448
Liliana Garcia-Martinez United States 6 270 1.2× 93 0.6× 89 1.4× 67 2.0× 11 0.4× 7 371
Patrícia Izetti Brazil 6 217 0.9× 148 0.9× 140 2.3× 39 1.1× 24 1.0× 6 364
Andreana Holowatyj United States 7 414 1.8× 78 0.5× 59 1.0× 27 0.8× 17 0.7× 8 452

Countries citing papers authored by Hongjian Yang

Since Specialization
Citations

This map shows the geographic impact of Hongjian Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongjian Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongjian Yang more than expected).

Fields of papers citing papers by Hongjian Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongjian Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongjian Yang. The network helps show where Hongjian Yang may publish in the future.

Co-authorship network of co-authors of Hongjian Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Hongjian Yang. A scholar is included among the top collaborators of Hongjian Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongjian Yang. Hongjian Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mao, Jiefei, Ning Xu, Qing Liu, et al.. (2025). LncRNA-MALAT1 promotes triple-negative breast cancer progression and function as ceRNA to target REEP5 by sponging miR-106a-5p. European journal of medical research. 30(1). 159–159. 2 indexed citations
2.
You, Qiang, et al.. (2025). Forensic Support for Abraham et al.’s BB Protocol. Entropy. 27(5). 504–504.
3.
Yang, Qiuhui, et al.. (2023). New progress in the role of microRNAs in the diagnosis and prognosis of triple negative breast cancer. Frontiers in Molecular Biosciences. 10. 1162463–1162463. 9 indexed citations
4.
Song, Yuqin, Youngil Koh, Ji Cao, et al.. (2021). EARLY SAFETY AND EFFICACY DATA FROM A PHASE I/II TRIAL OF DZD4205, A SELECTIVE JAK1 INHIBITOR, IN RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA. Hematological Oncology. 39(S2). 3 indexed citations
5.
Qiao, Enqi, et al.. (2021). Curcuma zedoaria petroleum ether extract reverses the resistance of triple-negative breast cancer to docetaxel via pregnane X receptor. Annals of Translational Medicine. 9(17). 1389–1389. 3 indexed citations
6.
Li, Yongfeng, et al.. (2021). LncRNA AWPPH as a prognostic predictor in human cancers in Chinese population: evidence from meta-analysis. Bioscience Reports. 41(6). 1 indexed citations
7.
Zhang, Xiping & Hongjian Yang. (2020). Research Progress on Long Non-coding RNAs and Drug Resistance of Breast Cancer. Clinical Breast Cancer. 20(4). 275–282. 6 indexed citations
8.
Wang, Chen, et al.. (2018). Knockdown of ribosomal protein S15A inhibits proliferation of breast cancer cells through induction of apoptosis in vitro. Cytotechnology. 70(5). 1315–1323. 9 indexed citations
9.
Wang, Chen, Hongjian Yang, Xingfei Yu, et al.. (2018). The Dysregulated Expression of KCNQ1OT1 and Its Interaction with Downstream Factors miR-145/CCNE2 in Breast Cancer Cells. Cellular Physiology and Biochemistry. 49(2). 432–446. 57 indexed citations
10.
Zheng, Yabing, Xiying Shao, Yu‐An Huang, et al.. (2016). Role of estrogen receptor in breast cancer cell gene expression. Molecular Medicine Reports. 13(5). 4046–4050. 11 indexed citations
11.
Meng, Xuli, Hongchao Tang, Weimin Mao, et al.. (2015). Drug response to HER2 gatekeeper T798M mutation in HER2-positive breast cancer. Amino Acids. 48(2). 487–497. 12 indexed citations
12.
Yang, Hongjian, et al.. (2015). Integrated analysis of differentially expressed genes in breast cancer pathogenesis. Oncology Letters. 9(6). 2560–2566. 15 indexed citations
13.
Yang, Hongjian, Xiangming He, Yabing Zheng, et al.. (2014). Down‐Regulation of Asparagine Synthetase Induces Cell Cycle Arrest and Inhibits Cell Proliferation of Breast Cancer. Chemical Biology & Drug Design. 84(5). 578–584. 44 indexed citations
14.
Ding, Xianfeng, Ting Ji, Xiping Zhang, et al.. (2014). Long Intergenic Non-Coding RNAs (LincRNAs) Identified by RNA-Seq in Breast Cancer. PLoS ONE. 9(8). e103270–e103270. 47 indexed citations
15.
Yang, Hongjian, Yabing Zheng, Xingfei Yu, et al.. (2014). shRNA-mediated silencing of ZFX attenuated the proliferation of breast cancer cells. Cancer Chemotherapy and Pharmacology. 73(3). 569–576. 29 indexed citations
16.
He, Xiangming, Hua Xiang, Xiangyun Zong, et al.. (2014). CDK2-AP1 inhibits growth of breast cancer cells by regulating cell cycle and increasing docetaxel sensitivity in vivo and in vitro. Cancer Cell International. 14(1). 130–130. 27 indexed citations
17.
Cao, Wen‐Ming, Xiaojia Wang, Yun Gao, Hongjian Yang, & Ji‐Cheng Li. (2012). BRCA1 Germ‐Line Mutations and Tumor Characteristics in Eastern Chinese Women with Familial Breast Cancer. The Anatomical Record. 296(2). 273–278. 14 indexed citations
18.
Yu, Yang, Jianguo Feng, Xiangyun Zong, et al.. (2011). Knockdown of vascular endothelial cell growth factor expression sensitizes U251 glioma cells to liposomal paclitaxel and radiation treatment in vitro. Experimental and Therapeutic Medicine. 3(2). 181–186. 3 indexed citations
19.
Mao, Weimin, Hongjian Yang, Xiaozhong Chen, et al.. (2009). [Study on cancer incidence through the cancer registry program in 11 cities and counties, China].. PubMed. 30(11). 1165–70. 15 indexed citations
20.
Ding, Xiaowen, et al.. (2004). [CHL prevent colon neoplasms in mice and its selective inhibition on COX-2].. PubMed. 23(11 Suppl). 1409–13. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huangzhen Wang Breakdown of academic impact, for papers by Binbin Cui Breakdown of academic impact, for papers by Jing Cui Breakdown of academic impact, for papers by Qianfeng Shi Breakdown of academic impact, for papers by Maria Sandbothe Breakdown of academic impact, for papers by Faying Xu Breakdown of academic impact, for papers by Rosario Machado-Pinilla Breakdown of academic impact, for papers by Liliana Garcia-Martinez Breakdown of academic impact, for papers by Patrícia Izetti Breakdown of academic impact, for papers by Andreana Holowatyj
Rankless by CCL
2026